Approval · Notice of Compliance 16873 · 2015
OSPHOS INJECTION: Notice of Compliance 16873
Issued May 6, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16873
- Date
- May 6, 2015
- Company
- Dechra LtdSkipton, North Yorkshire, United Kingdom
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bisphosphonate
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OSPHOS INJECTION | 02440776 | Marketed |
Medicinal ingredients
- CLODRONATE DISODIUM TETRAHYDRATE 60 MG per ML